Does CAPMATINIB Cause Pleural effusion? 55 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 55 reports of Pleural effusion have been filed in association with CAPMATINIB (TABRECTA). This represents 2.4% of all adverse event reports for CAPMATINIB.
55
Reports of Pleural effusion with CAPMATINIB
2.4%
of all CAPMATINIB reports
7
Deaths
26
Hospitalizations
How Dangerous Is Pleural effusion From CAPMATINIB?
Of the 55 reports, 7 (12.7%) resulted in death, 26 (47.3%) required hospitalization, and 2 (3.6%) were considered life-threatening.
Is Pleural effusion Listed in the Official Label?
Yes, Pleural effusion is listed as a known adverse reaction in the official FDA drug label for CAPMATINIB.
What Other Side Effects Does CAPMATINIB Cause?
Death (411)
Peripheral swelling (283)
Fatigue (257)
Oedema peripheral (247)
Nausea (240)
Malignant neoplasm progression (178)
Dyspnoea (141)
Oedema (130)
Asthenia (113)
Non-small cell lung cancer (96)
What Other Drugs Cause Pleural effusion?
DASATINIB (2,424)
METHOTREXATE (1,310)
CYCLOPHOSPHAMIDE (1,239)
IBRUTINIB (1,205)
RITUXIMAB (1,168)
PREDNISONE (1,144)
NIVOLUMAB (1,061)
ADALIMUMAB (1,036)
DEXAMETHASONE (879)
PACLITAXEL (862)
Which CAPMATINIB Alternatives Have Lower Pleural effusion Risk?
CAPMATINIB vs CAPREOMYCIN
CAPMATINIB vs CAPSAICIN
CAPMATINIB vs CAPTOPRIL
CAPMATINIB vs CARBAMAZEPINE
CAPMATINIB vs CARBETOCIN